•
Sep 30, 2019

CRISPR Therapeutics Q3 2019 Earnings Report

Total Revenue
$212M
Previous year: $563K
+37542.6%
EPS
$2.4
Previous year: -$1.07
-324.3%
Gross Profit
$155M
Previous year: -$39.3M
-494.0%
Cash and Equivalents
$630M
Previous year: $487M
+29.2%
Free Cash Flow
$131M
Previous year: -$20.7M
-733.9%
Total Assets
$721M
Previous year: $519M
+38.9%

CRISPR Therapeutics

CRISPR Therapeutics

CRISPR Therapeutics Revenue by Segment